Afya Reports Strong 2025 Results, Declares Substantial Dividend, and Expands Medical School Capacity

summarizeSummary

Afya Ltd announced strong full-year 2025 financial results with significant revenue and net income growth, declared a substantial cash dividend, and received approval for additional medical school seats.

check_boxKey Events

• Strong Full-Year 2025 Financial Performance

  Afya reported full-year 2025 revenue of R$3,697,255 thousand, an 11.9% increase from 2024, and net income of R$768,443 thousand, an 18.4% increase year-over-year. Basic earnings per share rose to R$8.32 from R$7.01 in 2024.

• Substantial Cash Dividend Declared

  The Board of Directors approved a cash dividend distribution of R$307.4 million, representing 40% of the Company's consolidated net income for 2025. This translates to R$3.446838 per share, payable on April 6, 2026, to shareholders on record as of March 25, 2026.

• Operational Expansion with New Medical Seats

  The Ministry of Education (MEC) authorized an increase of 63 medical school seats for ITPAC Porto in Abaetetuba, State of Pará, bringing the total to 113 seats on that campus.

auto_awesomeAnalysis

Afya Ltd delivered robust full-year 2025 financial results, showcasing significant growth in both revenue and net income. This strong performance underpins a substantial cash dividend declaration, representing a significant portion of the year's net income. The regulatory approval for additional medical school seats further signals operational growth and future revenue potential. This comprehensive positive news is particularly impactful as the company's stock is currently trading near its 52-week low, potentially attracting renewed investor interest.